Physician
Pediatric Care Center, P.L.L.C.
Pediatric Care Center, P.L.L.C. was paid $3.86M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 60% of everything it billed.
33Billing provider infoPEDIATRIC CARE CENTER, P.L.L.C.
PASCAGOULA, MS 39581
PASCAGOULA, MS 39581
33aNPI1083719256assigned 09/13/2006
33bProvider typePediatrics Physician
28Total paid$3.86M
24GClaims98,016
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Mississippi
Rank by total paid#12 of 86
Median peer was paid$221K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,205 | $759K | |
| 2019 | 21,799 | $741K | |
| 2020 | 17,021 | $588K | |
| 2021 | 14,791 | $609K | |
| 2022 | 13,466 | $574K | |
| 2023 | 7,092 | $398K | |
| 2024incomplete | 3,642 | $194K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 60% | 41,611 | 34,523 | $2.34M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.3% | 3,983 | 3,522 | $320K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.5% | 2,973 | 2,745 | $252K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 2,653 | 2,377 | $211K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.4% | 7,899 | 7,164 | $208K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 2,063 | 1,810 | $176K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 838 | 666 | $65K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 4,864 | 2,107 | $59K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 4,168 | 3,807 | $53K |
| 90461 | 1.1% | 4,714 | 4,389 | $42K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 265 | 243 | $27K |
| 96127 | <1% | 4,498 | 2,394 | $15K |
45 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 383 | $14K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 212 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 326 | $13K |
| 92551 | <1% | 1,426 | $11K | |
| 99050 | <1% | 698 | $9K | |
| 99381 | <1% | 66 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 373 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 166 | $3K |
| 87807 | <1% | 278 | $3K | |
| 99173 | <1% | 1,249 | $3K | |
| 87420 | <1% | 341 | $3K | |
| 81002 | <1% | 1,044 | $3K | |
| 0071A | <1% | 110 | $3K | |
| 90677 | <1% | 139 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 186 | $2K |
| 90697 | <1% | 276 | $2K | |
| 85018 | <1% | 1,094 | $2K | |
| 92587 | <1% | 63 | $795.58 | |
| 83655 | <1% | 82 | $770.35 | |
| 90710 | <1% | 758 | $693.01 | |
| 90670 | <1% | 2,880 | $607.52 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 36 | $386.84 |
| 81000 | <1% | 172 | $317.01 | |
| 96160 | <1% | 138 | $234.84 | |
| 99441 | <1% | 31 | $183.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 92 | $124.67 |
| 85014 | <1% | 81 | $121.65 | |
| 90715 | <1% | 212 | $91.69 | |
| 90696 | <1% | 126 | $75.20 | |
| 90686 | <1% | 649 | $57.03 | |
| 90723 | <1% | 422 | $50.40 | |
| 99177 | <1% | 28 | $4.73 | |
| 90649 | <1% | 248 | $1.12 | |
| 90648 | <1% | 838 | $0.86 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 374 | $0.42 |
| 90698 | 0% | 660 | $0.00 | |
| 99000 | 0% | 71 | $0.00 | |
| 90744 | 0% | 175 | $0.00 | |
| 36416 | 0% | 159 | $0.00 | |
| 97802 | 0% | 26 | $0.00 | |
| 91307 | 0% | 72 | $0.00 | |
| 94760 | 0% | 15 | $0.00 | |
| 90681 | 0% | 642 | $0.00 | |
| 90633 | 0% | 30 | $0.00 | |
| 90700 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOFFMAN, NIKKI (OFFICE MANAGER)